{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/6398bb70ee249200127c1182/6a96ddc60cefab27306c0108?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"The Next Frontier in Cancer Care: Inside Histotripsy","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/6398bb70ee249200127c1182/1788272017446-8d119bc9-eb3a-4098-a6f7-2e1a57758072.jpeg?height=200","description":"<p>Dr. Daniel Labow, Chair of Surgical Services, Surgical Oncology at Northwell Health, joins Lisa Wexler to discuss Histotripsy, an innovative, non-invasive, incisionless ultrasound treatment for liver tumors now only available at Northwell Health’s Norwalk Hospital. He explains how this breakthrough technology works, its potential to treat other organs in the future, and what it means for patients. Dr. Labow also shares practical guidance on cancer prevention, what early warning signs to watch for, and the critical first steps patients should take if symptoms arise.</p>","author_name":"The Lisa Wexler Show"}